Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon

References

• Committee on Patient Safety and Health Information Technology; Institute of Medicine. Health IT and Patient Safety: Building Safer Systems for Better Care. Washington (DC): National Academies Press (US), 2011
   Google Scholar
• Assiri GA, Grant L, Aljadhey H, Sheikh A. Investigating the epidemiology of medication errors and error-related adverse drug events (ADEs) in primary care, ambulatory care and home settings: a systematic review protocol. BMJ Open 2016;6:e010675
   PubMed Web of Science ®Google Scholar
• World Health Organization. Safety of Medicines – A Guide to Detecting and Reporting Adverse Drug Reactions – Why Health Professionals Need to Take Action 2002. Available at: http://apps.who.int/medicinedocs/en/d/Jh2992e/1.html. accessed on April 4, 2017
   Google Scholar
• Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001;41:192-9
   PubMedGoogle Scholar
• Hallit RR, Afridi M, Sison R, et al. AIDS-related lymphoma: resolution with antiretroviral therapy alone. J Int Assoc Providers AIDS Care 2014;13:313-15
   Google Scholar
• Zhang L, Yan J, Liu X, et al. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. J Ethnopharmacol 2012;140:519-25
   PubMed Web of Science ®Google Scholar
• Griffin JP. The evolution of human medicines control from a national to an international perspective. Adverse Drug React Toxicol Rev 1998;17:19-50
   PubMedGoogle Scholar
• Kongkaew C, Hann M, Mandal J, et al. Risk factors for hospital admissions associated with adverse drug events. Pharmacotherapy 2013;33:827-37
   PubMed Web of Science ®Google Scholar
• Hoonhout LH, de Bruijne MC, Wagner C, et al. Direct medical costs of adverse events in Dutch hospitals. BMC Health Serv Res 2009;9:27
   PubMed Web of Science ®Google Scholar
• Qing-ping S, Xiao-dong J, Feng D, et al. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China. BMC Health Serv Res 2014;14:73
   PubMed Web of Science ®Google Scholar
• Gillespie U, Morlin C, Hammarlund-Udenaes M, Hedstrom M. Perceived value of ward-based pharmacists from the perspective of physicians and nurses. Int J Clin Pharm 2012;34:127-35
   PubMed Web of Science ®Google Scholar
• Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006;166:955-64
   PubMed Web of Science ®Google Scholar
• Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70
   PubMed Web of Science ®Google Scholar
• van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists’ role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf 2004;13:457-64
   PubMed Web of Science ®Google Scholar
• Bhuvan KC, Alrasheedy AA, Ibrahim MI. Do community pharmacists in Nepal have a role in adverse drug reaction reporting systems?. The Australasian medical journal. 2013;6:100
   PubMedGoogle Scholar
• World Health Organization. Essential medicines and health products: Pharmacovigilance. Available at: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/. accessed on April 24, 2017
   Google Scholar
• Gavaza P, Brown CM, Lawson KA, et al. Pharmacist reporting of serious adverse drug events to the Food and Drug Administration. J Am Pharmacists Assoc 2012;52:e109-12
   PubMed Web of Science ®Google Scholar
• Suyagh M, Farah D, Abu Farha R. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharmaceut J 2015;23:147-53
   PubMed Web of Science ®Google Scholar
• Kassab IA, Bouchi N, Bagheri H, Geahchan A. [Setup of a national system of adverse drug reaction reporting in Lebanon: results of the first year of activity]. Therapie 2005;60:583-7
   PubMed Web of Science ®Google Scholar
• Order of Pharmacists in Lebanon website 2016. Available at: http://www.opl.org.lb/. accessed on February 4, 2017
   Google Scholar
• Centers for Disease Control and Prevention. Epi info 7. Available at: http://wwwn.cdc.gov/epiinfo/7/index.htm. accessed on February 8, 2017
   Google Scholar
• Alshakka MA, Ibrahim MI, Hassali MA. Do health professionals have positive perception towards consumer reporting of adverse drug reactions? J Clin Diagn Res 2013;7:2181-5
   PubMedGoogle Scholar
• Elkalmi RM, Hassali MA, Ibrahim MI, et al. Community pharmacists’ attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight. J Patient Saf 2014;10:81-7
   PubMed Web of Science ®Google Scholar
• Rayes IK, Hassali MA, Abduelkarem AR. A qualitative study exploring public perceptions on the role of community pharmacists in Dubai. Pharm Pract 2014;12:363
   PubMedGoogle Scholar
• Gavaza P, Brown CM, Lawson KA, et al. Texas pharmacists’ knowledge of reporting serious adverse drug events to the Food and Drug Administration. J Am Pharmacists Assoc 2011;51:397-403
   PubMed Web of Science ®Google Scholar
• Gavaza P, Brown CM, Lawson KA, et al. Influence of attitudes on pharmacists’ intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol 2011;72:143-52
   PubMed Web of Science ®Google Scholar
• Gavaza P, Brown CM, Lawson KA, et al. Examination of pharmacists’ intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res Soc Admin Pharm 2011;7:369-82
   PubMed Web of Science ®Google Scholar
• Jose J, Jimmy B, Al-Ghailani AS, Al Majali MA. A cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of Oman. Saudi Pharmaceut J 2014;22:163-9
   PubMed Web of Science ®Google Scholar
• Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci 2009;31:183-7
   PubMedGoogle Scholar
• Yu YM, Lee E, Koo BS, et al. Predictive factors of spontaneous reporting of adverse drug reactions among community pharmacists. PloS One 2016;11:e0155517
   PubMed Web of Science ®Google Scholar
• Introduction to Post marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER 2013. Available at: http://www.fda.gov/downloads/AboutFDA/WorkingatFDA/FellowshipInternshipGraduateFacultyPrograms/PharmacyStudentExperientialProgramCDER/UCM340626.pdf. accessed on April 8, 2017
   Google Scholar
• Irujo M, Beitia G, Bes-Rastrollo M, et al. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf 2007;30:1073-82
   PubMed Web of Science ®Google Scholar
• Khalili H, Mohebbi N, Hendoiee N, et al. Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre- and post-clinical pharmacists’ interventional study. BMJ Open 2012;2:e000367
   PubMed Web of Science ®Google Scholar
• Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf 2010;19:217-22
   PubMed Web of Science ®Google Scholar
• Bawazir OA, Alsuwayt B, Alqahtani W, et al. Knowledge, attitude and practice of pediatricians and pharmacists in Riyadh City toward the use of sugar free medications. J Contemp Dent Pract 2014;15:755-60
   PubMedGoogle Scholar
• Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf 2000;23:165-72
   Web of Science ®Google Scholar
• Ribeiro-Vaz I, Herdeiro MT, Polonia J, Figueiras A. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Revista de Saude Publica 2011;45:129-35
   PubMed Web of Science ®Google Scholar
• Herdeiro MT, Polonia J, Gestal-Otero JJ, Figueiras A. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Drug Saf 2008;31:335-44
   Web of Science ®Google Scholar
• Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006;296:1086-93
   PubMed Web of Science ®Google Scholar
• Prakasam A, Nidamanuri A, Kumar S. Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India. Pharm Pract 2012;10:222-6
   PubMedGoogle Scholar
• Palaian S, Ibrahim MI, Mishra P. Pattern of adverse drug reactions reported by the community pharmacists in Nepal. Pharm Pract 2010;8:201-7
   PubMedGoogle Scholar
• Abadie D, Chebane L, Bert M, et al. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center. Therapie 2014;69:395-400
   PubMed Web of Science ®Google Scholar
• Sanchez I, Amador C, Plaza JC, et al. [Assessment of an active pharmacovigilance system carried out by a pharmacist]. Rev Med Chil 2014;142:998-1005
   PubMed Web of Science ®Google Scholar